Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction

المؤلفون المشاركون

Twilla, Jennifer D.
Pierce, Andrew S.

المصدر

Case Reports in Psychiatry

العدد

المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-3، 3ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2014-07-17

دولة النشر

مصر

عدد الصفحات

3

التخصصات الرئيسية

علم النفس
الطب النفسي

الملخص EN

Valproic acid-induced hyperammonemic encephalopathy is a rare yet serious adverse drug reaction.

Medication interactions such a valproic acid and topiramate can precipitate an event.

We present the case of a 52-year-old female that presented with acute mental status change and hypersomnolence due to hyperammonemia caused by a valproic acid derivative.

The patient improved after withdrawal of the offending medications and treatment with lactulose.

Clinicians should remain hypervigilant in monitoring for valproic acid-induced hyperammonemic encephalopathy and risk factors such as polypharmacy.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Twilla, Jennifer D.& Pierce, Andrew S.. 2014. Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction. Case Reports in Psychiatry،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-469955

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Twilla, Jennifer D.& Pierce, Andrew S.. Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction. Case Reports in Psychiatry No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-469955

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Twilla, Jennifer D.& Pierce, Andrew S.. Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction. Case Reports in Psychiatry. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-469955

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-469955